Recent advancements in cancer diagnosis and treatment are showing promising results. A new clinical trial for Hodgkin lymphoma demonstrated that combining chemotherapy with the antibody Nivolumab led to a 94% cancer-free rate in patients, significantly better than the current standard of care (WAFB). In a separate initiative, cancer screening tests for individuals over 35 are being conducted in Paderu, India, highlighting the importance of early detection (The Hindu). Additionally, a novel at-home Gut ID test can identify harmful gut bacteria linked to cancer and IBS, allowing for early intervention (Yahoo News). Research on extracellular vesicles has uncovered new RNA biomarkers in prostate cancer patients, potentially revolutionizing non-invasive diagnostics (Archyde). Lastly, the POSEIDON program aims to create self-administered, over-the-counter cancer screening tools to catch cancers at Stage I, promoting proactive health management (Politico).